Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Viewpoint
  • Published:

What are the options for upgrading the quality of clinical assessment and research in Barrett's esophagus?

Nature Clinical Practice Gastroenterology & Hepatology volume 3, pages 650–651 (2006)Cite this article

Patients with Barrett's esophagus and their doctors face major difficulties regarding the management of this condition. There is insufficient authoritative and reliable evidence on which to base management plans, and it is difficult, therefore, to explain to a patient why a particular approach should be used, and to adequately tailor a management plan to the characteristics and preferences of an individual.

The only major clinical significance of Barrett's esophagus is a relatively modest overall risk for developing esophageal adenocarcinoma. Screening, surveillance, and intervention (if necessary) are all believed to reduce the risk of death from esophageal adenocarcinoma in patients with Barrett's esophagus. It is clinically inappropriate and medicolegally dangerous, therefore, not to discuss the risks and benefits of various management options formally with patients.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Meining A et al. (2004) The Munich Barrett follow-up study: suspicion of Barrett's esophagus based on either endoscopy or histology only—what is the clinical significance? Gut 53: 1402–1407

    Article  CAS  Google Scholar 

  2. Avidan B et al. (2002) Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma. Am J Gastroenterol 97: 1930–1936

    Article  Google Scholar 

  3. Sharma P et al. The development and validation of an endoscopic grading system for Barrett's esophagus—the Prague C and M criteria. Gastroenterology, in press

  4. Dent J (2006) Pathogenesis and classification of cancer around the gastroesophageal junction—not so different in Japan. Am J Gastroenterol 101: 934–936

    Article  Google Scholar 

  5. Vakil N et al. (2006) The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101: 1900–1920

    Article  Google Scholar 

  6. Reid BJ et al. (2000) Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastroenterol 95: 3089–3096

    Article  CAS  Google Scholar 

  7. Jones TF et al. (2002) Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy. Dig Dis Sci 27: 2108–2011

    Article  Google Scholar 

  8. Stein HJ (1996) Esophageal cancer: screening and surveillance. Results of a consensus conference held at the VIth world congress of the International Society for Diseases of the Esophagus. Dis Esophagus 9 (Suppl 1): 3–19

    Google Scholar 

  9. MacNeil-Covin L et al. (2003) A survey of Canadian gastroenterologists about the management of Barrett's esophagus. Can J Gastroenterol 17: 313–317

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Professor and Director of the Nerve–Gut Laboratory in the Department of Gastroenterology, Hepatology & General Medicine, Royal Adelaide Hospital, Adelaide, Australia

    John Dent

Authors
  1. John Dent
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dent, J. What are the options for upgrading the quality of clinical assessment and research in Barrett's esophagus?. Nat Rev Gastroenterol Hepatol 3, 650–651 (2006). https://doi.org/10.1038/ncpgasthep0653

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0653

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing